Anika Therapeutics Inc (ANIK)

EBITDA

$4.89M

Quarterly · Period ending: · USD

ANIK logo

ANIK EBITDA

Latest reported$4.89M
ANIK Quarterly EBITDA (-$400.00K → $4.89M)
High-resolution chart · PNG

ANIK ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
4,885,000
-3,414,000
2,082,000
-833,000
-2,550,000
-2,277,000
26,529,000
-25,423,000
843,000
-2,408,000
1,983,000
-3,497,000
480,000
-8,463,000
-2,725,000
-1,867,000
424,000
63,000
-4,568,000
1,426,000
-967,000
-54,000
-2,566,000
-273,000
-1,642,000
3,477,000
6,334,000
13,565,000
13,617,000
7,754,000
11,239,000
10,086,000
12,693,000
-6,264,000
10,794,000
11,471,000
18,734,000
9,020,000
13,697,000
14,565,000
14,428,000
11,651,000
18,040,579
13,135,114
12,428,688
6,418,320
13,216,546
11,496,248
16,370,325
25,069,367
11,779,571
8,878,768
10,356,000
6,078,025
11,490,311
3,909,063
6,133,870
3,063,060
5,974,881
4,817,362
3,677,577
556,679
3,342,861
2,077,637
1,804,049
1,177,790
4,051,008
2,016,253
1,542,770
759,368
1,599,342
1,331,468
890,884
755,753
2,402,488
2,069,619
1,549,660
1,384,391
960,810
1,807,351
1,916,925
1,126,442
973,000
4,040,000
2,082,000
1,914,000
2,576,000
1,692,000
1,460,000
1,205,000
1,092,000
391,000
127,000
-261,000
886,649
-692,644
-947,248
-1,595,878
-244,126
-1,084,157
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.